Company Name, Ticker, Suppliers, else..

Worst Performing Stocks In Total Market During The Last 5 Days

1 Day

Week

Current Month of February

30 Days

Current Quarter Q1 of 2025

90 Days

Ytd

12 Months

Shares declined by -0.91% on average, in Total Market during the last 5 days.

Here are the Worst performing stocks in Total Market.

VLCN

$1.15

$-0.6800

-37.16%
Last 5 Days

VLCN

$1.15

$-0.6800

-37.16%

Volcon Inc

Volcon Inc shares dropped -37.16% during the last 5 days.

Volcon Inc operates a business model focused on manufacturing and selling electric powersports vehicles. They design and produce a range of off-road motorcycles, including dirt bikes and adventure bikes, as well as electric utility vehicles. Their products are aimed at providing sustainable, environmentally friendly alternatives to traditional gasoline-powered off-road vehicles.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.082 mill.	$ 4.134 mill.	$ -87.417 mill.	0 mill.	-	Y/Y 120.72 %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.082 mill.	$ 4.134 mill.	$ -87.417 mill.
Employees	Shares Outstanding	P/E
22	0 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 120.72 %	MRQ Y/Y - %

ULH

$28.295

$-15.3350

-35.15%
Last 5 Days

ULH

$28.295

$-15.3350

-35.15%

Universal Logistics Holdings Inc

Universal Logistics Holdings Inc shares declined -35.15% during the last 5 days.

Universal Logistics Holdings Inc is a transportation and logistics company that offers a comprehensive suite of services including transportation, intermodal, and value-added solutions to meet the diverse needs of its customers. It operates through a network of owned and contracted transportation equipment, providing customized solutions for various industries.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 745.658 mill.	$ 1,771.824 mill.	$ 131.143 mill.	26 mill.	5.68	Y/Y 1.33 %

Market Cap.	Revenues TTM	Net Income TTM
$ 745.658 mill.	$ 1,771.824 mill.	$ 131.143 mill.
Employees	Shares Outstanding	P/E
12,000	26 mill.	5.68
Revenue Growth	Income Growth
MRQ Y/Y 1.33 %	MRQ Y/Y 15.16 %

HYPR

$1.12

$-0.5000

-30.86%
Last 5 Days

HYPR

$1.12

$-0.5000

-30.86%

Hyperfine Inc

Hyperfine Inc stock went down -30.86% during the last 5 days.

Hyperfine Inc operates on a business model that focuses on designing and manufacturing portable and affordable magnetic resonance imaging (MRI) systems, enabling medical professionals to access advanced imaging technology at a lower cost, expanding the reach of MRI diagnostics.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 81.400 mill.	$ 10.189 mill.	$ -41.087 mill.	73 mill.	-	Y/Y 18.99 %

Market Cap.	Revenues TTM	Net Income TTM
$ 81.400 mill.	$ 10.189 mill.	$ -41.087 mill.
Employees	Shares Outstanding	P/E
140	73 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 18.99 %	MRQ Y/Y - %

FBRX

$10.55

$-4.4500

-29.67%
Last 5 Days

FBRX

$10.55

$-4.4500

-29.67%

Forte Biosciences Inc

Forte Biosciences Inc stock dropped -29.67% during the last 5 days.

Forte Biosciences Inc is a biotechnology company focused on developing and commercializing innovative solutions for the treatment of dermatological diseases. Their business model centers around researching, developing, and bringing to market products that address unmet needs in the field of skin health through their proprietary technology platform.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 19.501 mill.	$ - mill.	$ -34.195 mill.	2 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 19.501 mill.	$ - mill.	$ -34.195 mill.
Employees	Shares Outstanding	P/E
14	2 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

PTIX

$0.27

$-0.1046

-27.92%
Last 5 Days

PTIX

$0.27

$-0.1046

-27.92%

Protagenic Therapeutics Inc new

Protagenic Therapeutics Inc New shares dropped -27.92% during the last 5 days.

Protagenic Therapeutics Inc has developed a novel business model focused on the discovery and development of novel therapeutics targeting the PGRMC1 receptor, which plays a crucial role in various diseases. By leveraging their proprietary technology and partnerships, the company aims to advance the development of innovative drugs that can effectively treat a range of conditions influenced by the PGRMC1 receptor.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 1.223 mill.	$ - mill.	$ -5.648 mill.	5 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 1.223 mill.	$ - mill.	$ -5.648 mill.
Employees	Shares Outstanding	P/E
10	5 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

ACH-USD

$0.0268

$-0.0095

-26.17%
Last 5 Days

ACH-USD

$0.0268

$-0.0095

-26.17%

Alchemy Pay

Alchemy Pay stock dropped -26.17% during the last 5 days.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.121 mill.	$ - mill.	$ -5.648 mill.	5 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.121 mill.	$ - mill.	$ -5.648 mill.
Employees	Shares Outstanding	P/E
-	5 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

ORIC

$9.335

$-3.0550

-24.66%
Last 5 Days

ORIC

$9.335

$-3.0550

-24.66%

Oric Pharmaceuticals Inc

Oric Pharmaceuticals Inc stock went down -24.66% during the last 5 days.

Oric Pharmaceuticals Inc*s business model focuses on the development and commercialization of innovative therapeutics for the treatment of cancer.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 658.516 mill.	$ - mill.	$ -119.870 mill.	71 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 658.516 mill.	$ - mill.	$ -119.870 mill.
Employees	Shares Outstanding	P/E
74	71 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

NWL

$7.33

$-2.3700

-24.43%
Last 5 Days

NWL

$7.33

$-2.3700

-24.43%

Newell Brands Inc

Newell Brands Inc stock declined -24.43% during the last 5 days.

Newell Brands Inc operates under a diversified business model that encompasses a broad portfolio of consumer and commercial products. The company excels in the design, manufacturing, and distribution of household goods, office supplies, and storage solutions, utilizing its well-known brands to cater to various market segments. By focusing on innovation, efficiency, and strategic partnerships, Newell Brands aims to effectively address the evolving needs of consumers and businesses alike.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 3,049.280 mill.	$ 7,709.000 mill.	$ -248.000 mill.	416 mill.	-	Y/Y -4.93 %

Market Cap.	Revenues TTM	Net Income TTM
$ 3,049.280 mill.	$ 7,709.000 mill.	$ -248.000 mill.
Employees	Shares Outstanding	P/E
24,600	416 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -4.93 %	MRQ Y/Y - %

OLMA

$5.07

$-1.5600

-23.53%
Last 5 Days

OLMA

$5.07

$-1.5600

-23.53%

Olema Pharmaceuticals Inc

Olema Pharmaceuticals Inc shares declined -23.53% during the last 5 days.

Olema Pharmaceuticals Inc.*s business model focuses on the research, development, and commercialization of innovative cancer therapies.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 290.322 mill.	$ - mill.	$ -122.679 mill.	57 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 290.322 mill.	$ - mill.	$ -122.679 mill.
Employees	Shares Outstanding	P/E
45	57 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

EYPT

$5.98

$-1.8200

-23.33%
Last 5 Days

EYPT

$5.98

$-1.8200

-23.33%

Eyepoint Pharmaceuticals Inc

Eyepoint Pharmaceuticals Inc stock dropped -23.33% during the last 5 days.

Eyepoint Pharmaceuticals Inc is a pharmaceutical company that operates on a specialty business model focused on advancing ophthalmic therapies. They develop and commercialize innovative treatments using their proprietary drug delivery technology, allowing for sustained release of drugs to the eye. By leveraging their expertise in ophthalmology and controlled release technology, Eyepoint aims to improve patient outcomes and address unmet medical needs in eye care.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 325.605 mill.	$ 45.713 mill.	$ -103.570 mill.	54 mill.	-	Y/Y -30.77 %

Market Cap.	Revenues TTM	Net Income TTM
$ 325.605 mill.	$ 45.713 mill.	$ -103.570 mill.
Employees	Shares Outstanding	P/E
53	54 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -30.77 %	MRQ Y/Y - %

PETS

$4.12

$-1.2500

-23.28%
Last 5 Days

PETS

$4.12

$-1.2500

-23.28%

Petmed Express Inc

Petmed Express Inc shares went down -23.28% during the last 5 days.

Petmed Express Inc is a leading pet pharmacy that operates primarily through its online platform. They simplify the process of purchasing medication and pet supplies by offering a convenient and efficient delivery service directly to pet owners* homes. Their business model involves establishing a direct-to-consumer approach, providing competitive prices, and focusing on customer convenience to cater to the needs of pet owners across the United States.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 85.015 mill.	$ 247.368 mill.	$ 0.357 mill.	21 mill.	30.30	Y/Y -18.45 %

Market Cap.	Revenues TTM	Net Income TTM
$ 85.015 mill.	$ 247.368 mill.	$ 0.357 mill.
Employees	Shares Outstanding	P/E
148	21 mill.	30.30
Revenue Growth	Income Growth
MRQ Y/Y -18.45 %	MRQ Y/Y - %

EYEN

$1.84

$-0.5400

-22.69%
Last 5 Days

EYEN

$1.84

$-0.5400

-22.69%

Eyenovia inc

Eyenovia Inc shares went down -22.69% during the last 5 days.

Eyenovia Inc*s business model revolves around developing and commercializing innovative ophthalmic products utilizing its proprietary microfluidic ejection technology. The company aims to enhance treatment options for eye diseases and conditions by delivering more precise and targeted ocular therapeutics. Eyenovia focuses on creating user-friendly, high-precision, and cost-effective eye droppers to improve patient compliance and overall treatment outcomes.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 127.987 mill.	$ 0.032 mill.	$ -37.831 mill.	70 mill.	-	Y/Y 35.64 %

Market Cap.	Revenues TTM	Net Income TTM
$ 127.987 mill.	$ 0.032 mill.	$ -37.831 mill.
Employees	Shares Outstanding	P/E
10	70 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 35.64 %	MRQ Y/Y - %

UPB

$7.08

$-1.9400

-21.51%
Last 5 Days

UPB

$7.08

$-1.9400

-21.51%

Upstream Bio Inc

Upstream Bio Inc stock declined -21.51% during the last 5 days.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 21.404 mill.	$ 0.637 mill.	$ -45.935 mill.	3 mill.	-	Y/Y 50,567.78 %

Market Cap.	Revenues TTM	Net Income TTM
$ 21.404 mill.	$ 0.637 mill.	$ -45.935 mill.
Employees	Shares Outstanding	P/E
-	3 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 50,567.78 %	MRQ Y/Y - %

HUBC

$0.9625

$-0.2575

-21.11%
Last 5 Days

HUBC

$0.9625

$-0.2575

-21.11%

Hub Cyber Security Ltd

Hub Cyber Security Ltd stock went down -21.11% during the last 5 days.

Hub Cyber Security Ltd*s business model focuses on providing comprehensive cybersecurity solutions and services to businesses and organizations.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 81.807 mill.	$ 79.743 mill.	$ -80.000 mill.	85 mill.	-	Y/Y 0.00 %

Market Cap.	Revenues TTM	Net Income TTM
$ 81.807 mill.	$ 79.743 mill.	$ -80.000 mill.
Employees	Shares Outstanding	P/E
-	85 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 0.00 %	MRQ Y/Y - %

QTTB

$2.66

$-0.7000

-20.83%
Last 5 Days

QTTB

$2.66

$-0.7000

-20.83%

Q32 Bio Inc

Q32 Bio Inc shares declined -20.83% during the last 5 days.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 32.123 mill.	$ - mill.	$ -49.663 mill.	12 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 32.123 mill.	$ - mill.	$ -49.663 mill.
Employees	Shares Outstanding	P/E
42	12 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

HCTI

$0.5764

$-0.1385

-19.37%
Last 5 Days

HCTI

$0.5764

$-0.1385

-19.37%

Healthcare Triangle Inc

Healthcare Triangle Inc shares went down -19.37% during the last 5 days.

Healthcare Triangle Inc is a company that operates with a specific business model focused on providing healthcare solutions.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 3.064 mill.	$ 15.619 mill.	$ -5.158 mill.	5 mill.	-	Y/Y -69.67 %

Market Cap.	Revenues TTM	Net Income TTM
$ 3.064 mill.	$ 15.619 mill.	$ -5.158 mill.
Employees	Shares Outstanding	P/E
100	5 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -69.67 %	MRQ Y/Y - %

PI

$102.88

$-24.1800

-19.03%
Last 5 Days

PI

$102.88

$-24.1800

-19.03%

Impinj Inc

Impinj Inc stock went down -19.03% during the last 5 days.

Impinj Inc*s business model revolves around providing solutions for the Internet of Things (IoT) market through the development and production of RAIN RFID technologies. They offer a comprehensive platform that enables businesses to identify, locate, and authenticate items within the supply chain, thus improving operational efficiency and enhancing customer experiences.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 3,022.600 mill.	$ 365.855 mill.	$ 40.838 mill.	29 mill.	75.61	Y/Y 32.55 %

Market Cap.	Revenues TTM	Net Income TTM
$ 3,022.600 mill.	$ 365.855 mill.	$ 40.838 mill.
Employees	Shares Outstanding	P/E
475	29 mill.	75.61
Revenue Growth	Income Growth
MRQ Y/Y 32.55 %	MRQ Y/Y - %

FLGC

$0.8001

$-0.1879

-19.02%
Last 5 Days

FLGC

$0.8001

$-0.1879

-19.02%

Flora Growth Corp

Flora Growth Corp stock went down -19.02% during the last 5 days.

Flora Growth Corp*s business model focuses on the cultivation, processing, distribution, and sale of diverse cannabis and hemp-derived products in various international markets.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 7.134 mill.	$ 56.931 mill.	$ -63.626 mill.	9 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 7.134 mill.	$ 56.931 mill.	$ -63.626 mill.
Employees	Shares Outstanding	P/E
100	9 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

QURE

$13.08

$-3.0500

-18.91%
Last 5 Days

QURE

$13.08

$-3.0500

-18.91%

Uniqure N v

Uniqure N V shares declined -18.91% during the last 5 days.

Uniqure N.V*s business model revolves around developing and commercializing gene therapies to address rare genetic diseases.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 637.238 mill.	$ 23.305 mill.	$ -255.866 mill.	49 mill.	-	Y/Y -5.57 %

Market Cap.	Revenues TTM	Net Income TTM
$ 637.238 mill.	$ 23.305 mill.	$ -255.866 mill.
Employees	Shares Outstanding	P/E
100	49 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -5.57 %	MRQ Y/Y - %

VIVK

$0.825

$-0.1894

-18.67%
Last 5 Days

VIVK

$0.825

$-0.1894

-18.67%

Vivakor Inc

Vivakor Inc shares declined -18.67% during the last 5 days.

Vivakor Inc operates on a business model focused on technological innovations and resource acquisition. They identify and develop technologies that address global environmental and energy challenges, while leveraging strategic partnerships to acquire and monetize underutilized resources. By deploying their proprietary technologies and leveraging their network of partners, Vivakor aims to create sustainable solutions while generating revenue through the extraction of valuable resources.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 25.266 mill.	$ 61.992 mill.	$ -10.332 mill.	31 mill.	-	Y/Y -2.43 %

Market Cap.	Revenues TTM	Net Income TTM
$ 25.266 mill.	$ 61.992 mill.	$ -10.332 mill.
Employees	Shares Outstanding	P/E
4	31 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -2.43 %	MRQ Y/Y - %

IGMS

$1.295

$-0.2850

-18.04%
Last 5 Days

IGMS

$1.295

$-0.2850

-18.04%

Igm Biosciences Inc

Igm Biosciences Inc stock declined -18.04% during the last 5 days.

Igm Biosciences Inc*s business model focuses on the discovery and development of engineered Immunoglobulin M (IgM) antibodies to treat various diseases, primarily cancer.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 78.552 mill.	$ 2.869 mill.	$ -219.843 mill.	61 mill.	-	Y/Y 1.38 %

Market Cap.	Revenues TTM	Net Income TTM
$ 78.552 mill.	$ 2.869 mill.	$ -219.843 mill.
Employees	Shares Outstanding	P/E
224	61 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 1.38 %	MRQ Y/Y - %

EVGO

$2.755

$-0.6050

-18.01%
Last 5 Days

EVGO

$2.755

$-0.6050

-18.01%

Evgo Inc

Evgo Inc shares declined -18.01% during the last 5 days.

Evgo Inc operates an electric vehicle charging network, serving both individual customers and commercial fleet operators. Their business model revolves around building and maintaining a robust infrastructure of fast-charging stations strategically located across the United States. Through membership and pay-as-you-go options, they generate revenue by providing convenient and reliable charging services to electric vehicle owners, helping to promote the adoption of clean transportation.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 293.257 mill.	$ 238.865 mill.	$ -127.682 mill.	106 mill.	-	Y/Y 94.68 %

Market Cap.	Revenues TTM	Net Income TTM
$ 293.257 mill.	$ 238.865 mill.	$ -127.682 mill.
Employees	Shares Outstanding	P/E
219	106 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 94.68 %	MRQ Y/Y - %

FDMT

$5.035

$-1.1050

-18.00%
Last 5 Days

FDMT

$5.035

$-1.1050

-18.00%

4d Molecular Therapeutics Inc

4d Molecular Therapeutics Inc shares declined -18.00% during the last 5 days.

4D Molecular Therapeutics Inc operates with a business model focused on developing innovative gene therapy products to address serious genetic diseases. The company utilizes its proprietary technology platform to design and optimize viral vectors for targeted gene delivery. With a strong commitment to research and development, 4D Molecular Therapeutics collaborates with partners in academia, industry, and patient organizations to advance transformative treatments for patients in need.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 279.717 mill.	$ 0.018 mill.	$ -143.480 mill.	56 mill.	-	Y/Y -99.99 %

Market Cap.	Revenues TTM	Net Income TTM
$ 279.717 mill.	$ 0.018 mill.	$ -143.480 mill.
Employees	Shares Outstanding	P/E
90	56 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -99.99 %	MRQ Y/Y - %

HP

$27.23

$-5.9600

-17.96%
Last 5 Days

HP

$27.23

$-5.9600

-17.96%

Helmerich and Payne inc

Helmerich And Payne Inc shares went down -17.96% during the last 5 days.

Helmerich and Payne Inc. is a contract drilling company that operates primarily in the oil and gas industry. Their business model focuses on providing drilling services through the use of technologically advanced rigs and equipment. They generate revenue by entering into long-term contracts with exploration and production companies, offering drilling services from exploration to production phases.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 2,700.100 mill.	$ 2,756.762 mill.	$ 303.764 mill.	99 mill.	9.00	Y/Y 0.02 %

Market Cap.	Revenues TTM	Net Income TTM
$ 2,700.100 mill.	$ 2,756.762 mill.	$ 303.764 mill.
Employees	Shares Outstanding	P/E
8,820	99 mill.	9.00
Revenue Growth	Income Growth
MRQ Y/Y 0.02 %	MRQ Y/Y -42.45 %

VYGR

$4.65

$-1.0100

-17.84%
Last 5 Days

VYGR

$4.65

$-1.0100

-17.84%

Voyager Therapeutics Inc

Voyager Therapeutics Inc stock went down -17.84% during the last 5 days.

Voyager Therapeutics Inc. is a biopharmaceutical company that focuses on the development of gene therapies to treat severe neurological diseases. Their business model revolves around research, development, and commercialization of innovative treatments using viral gene therapy technology.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 269.008 mill.	$ 163.784 mill.	$ 25.880 mill.	58 mill.	8.88	Y/Y 433.79 %

Market Cap.	Revenues TTM	Net Income TTM
$ 269.008 mill.	$ 163.784 mill.	$ 25.880 mill.
Employees	Shares Outstanding	P/E
46	58 mill.	8.88
Revenue Growth	Income Growth
MRQ Y/Y 433.79 %	MRQ Y/Y - %

DLX

$18.555

$-4.0250

-17.83%
Last 5 Days

DLX

$18.555

$-4.0250

-17.83%

Deluxe Corporation

Deluxe Corporation shares went down -17.83% during the last 5 days.

Deluxe Corporation operates as a trusted provider of various business services and products, primarily focusing on check printing and related financial services catering to small businesses, financial institutions, and individual consumers. They aim to enhance the growth and success of their clients by offering customized solutions and innovative tools for marketing, payments, and other essential business operations.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 828.574 mill.	$ 2,138.580 mill.	$ 55.299 mill.	45 mill.	14.93	Y/Y -1.75 %

Market Cap.	Revenues TTM	Net Income TTM
$ 828.574 mill.	$ 2,138.580 mill.	$ 55.299 mill.
Employees	Shares Outstanding	P/E
5,170	45 mill.	14.93
Revenue Growth	Income Growth
MRQ Y/Y -1.75 %	MRQ Y/Y - %

HOTH

$1.0204

$-0.2196

-17.71%
Last 5 Days

HOTH

$1.0204

$-0.2196

-17.71%

Hoth Therapeutics Inc

Hoth Therapeutics Inc stock dropped -17.71% during the last 5 days.

Hoth Therapeutics Inc*s business model focuses on the development and commercialization of innovative therapies for dermatological disorders and other related conditions.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 7.045 mill.	$ - mill.	$ -7.892 mill.	7 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 7.045 mill.	$ - mill.	$ -7.892 mill.
Employees	Shares Outstanding	P/E
11	7 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

UPC

$0.1699

$-0.0356

-17.32%
Last 5 Days

UPC

$0.1699

$-0.0356

-17.32%

Universe Pharmaceuticals Inc

Universe Pharmaceuticals Inc shares declined -17.32% during the last 5 days.

Universe Pharmaceuticals Inc is a pharmaceutical company that follows a business model focused on research, development, and manufacturing of medications. They aim to identify and address unmet medical needs by developing innovative pharmaceutical products. Through strategic partnerships and collaborations, they strive to bring their products to market and provide effective healthcare solutions to patients worldwide.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.616 mill.	$ 32.309 mill.	$ -6.163 mill.	4 mill.	-	Y/Y -19.52 %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.616 mill.	$ 32.309 mill.	$ -6.163 mill.
Employees	Shares Outstanding	P/E
100	4 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -19.52 %	MRQ Y/Y - %

UBX

$1.9017

$-0.3983

-17.32%
Last 5 Days

UBX

$1.9017

$-0.3983

-17.32%

Unity Biotechnology Inc

Unity Biotechnology Inc stock went down -17.32% during the last 5 days.

Unity Biotechnology Inc. is a biotechnology company that focuses on developing therapies to treat age-related diseases. Their business model revolves around identifying and targeting specific senescent cells to address age-related conditions like osteoarthritis, kidney disease, and ophthalmic diseases. By leveraging their expertise in cellular senescence, Unity Biotechnology aims to develop innovative treatments that have the potential to extend healthy human lifespan.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 32.042 mill.	$ - mill.	$ -32.839 mill.	17 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 32.042 mill.	$ - mill.	$ -32.839 mill.
Employees	Shares Outstanding	P/E
57	17 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

PHAT

$5.26

$-1.0800

-17.03%
Last 5 Days

PHAT

$5.26

$-1.0800

-17.03%

Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals Inc stock dropped -17.03% during the last 5 days.

Phathom Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing treatments for gastrointestinal diseases. Their business model involves advancing their pipeline of drug candidates through research and development, and seeking regulatory approval for commercialization. By strategically targeting unmet medical needs in the gastrointestinal space, Phathom Pharmaceuticals aims to provide innovative solutions to improve patient outcomes.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 339.942 mill.	$ 26.270 mill.	$ -339.445 mill.	65 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 339.942 mill.	$ 26.270 mill.	$ -339.445 mill.
Employees	Shares Outstanding	P/E
72	65 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

ESOA

$9.15

$-1.8700

-16.97%
Last 5 Days

ESOA

$9.15

$-1.8700

-16.97%

Energy Services Of America Corp

Energy Services Of America Corp stock went down -16.97% during the last 5 days.

Energy Services of America Corporation operates as a diversified energy services company. They provide a wide range of construction, maintenance, and support services to the energy industry, including oil, gas, and utility companies. Their business model focuses on delivering quality services, maintaining client relationships, and maximizing customer satisfaction to drive growth and profitability.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 152.225 mill.	$ 361.379 mill.	$ 23.917 mill.	17 mill.	6.35	Y/Y 11.60 %

Market Cap.	Revenues TTM	Net Income TTM
$ 152.225 mill.	$ 361.379 mill.	$ 23.917 mill.
Employees	Shares Outstanding	P/E
339	17 mill.	6.35
Revenue Growth	Income Growth
MRQ Y/Y 11.60 %	MRQ Y/Y -58.20 %

VTHO-USD

$0.004

$-0.0008

-16.67%
Last 5 Days

VTHO-USD

$0.004

$-0.0008

-16.67%

VeThor Token

Vethor Token shares dropped -16.67% during the last 5 days.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 0.067 mill.	$ 361.379 mill.	$ 23.917 mill.	17 mill.	0.00	Y/Y 11.60 %

Market Cap.	Revenues TTM	Net Income TTM
$ 0.067 mill.	$ 361.379 mill.	$ 23.917 mill.
Employees	Shares Outstanding	P/E
-	17 mill.	0.00
Revenue Growth	Income Growth
MRQ Y/Y 11.60 %	MRQ Y/Y -58.20 %

HBIO

$1.385

$-0.2750

-16.57%
Last 5 Days

HBIO

$1.385

$-0.2750

-16.57%

Harvard Bioscience Inc

Harvard Bioscience Inc stock went down -16.57% during the last 5 days.

Harvard Bioscience Inc*s business model revolves around providing advanced tools and technologies to the life sciences research community. They offer a wide range of scientific instruments, equipment, and consumables that are used in various applications such as cell analysis, drug discovery, and next-generation sequencing.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 60.405 mill.	$ 96.451 mill.	$ -14.241 mill.	44 mill.	-	Y/Y -11.98 %

Market Cap.	Revenues TTM	Net Income TTM
$ 60.405 mill.	$ 96.451 mill.	$ -14.241 mill.
Employees	Shares Outstanding	P/E
416	44 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y -11.98 %	MRQ Y/Y - %

UI

$355.135

$-69.6450

-16.40%
Last 5 Days

UI

$355.135

$-69.6450

-16.40%

Ubiquiti Inc

Ubiquiti Inc stock went down -16.40% during the last 5 days.

offers equipment and related software platforms

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 21,495.256 mill.	$ 2,149.088 mill.	$ 444.877 mill.	61 mill.	48.28	Y/Y 28.96 %

Market Cap.	Revenues TTM	Net Income TTM
$ 21,495.256 mill.	$ 2,149.088 mill.	$ 444.877 mill.
Employees	Shares Outstanding	P/E
1,515	61 mill.	48.28
Revenue Growth	Income Growth
MRQ Y/Y 28.96 %	MRQ Y/Y 66.59 %

FATE

$1.19

$-0.2300

-16.20%
Last 5 Days

FATE

$1.19

$-0.2300

-16.20%

Fate Therapeutics Inc

Fate Therapeutics Inc stock dropped -16.20% during the last 5 days.

Fate Therapeutics Inc*s business model revolves around the development and commercialization of innovative cell-based therapies to treat various diseases.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 140.145 mill.	$ 13.447 mill.	$ -178.231 mill.	118 mill.	-	Y/Y 58.13 %

Market Cap.	Revenues TTM	Net Income TTM
$ 140.145 mill.	$ 13.447 mill.	$ -178.231 mill.
Employees	Shares Outstanding	P/E
220	118 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y 58.13 %	MRQ Y/Y - %

HAE

$60.28

$-10.9600

-15.38%
Last 5 Days

HAE

$60.28

$-10.9600

-15.38%

Haemonetics Corporation

Haemonetics Corporation shares went down -15.38% during the last 5 days.

Haemonetics Corporation*s business model revolves around providing innovative solutions and technologies for the collection, processing, and management of blood and its components.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 3,052.519 mill.	$ 1,372.814 mill.	$ 130.065 mill.	51 mill.	23.78	Y/Y 3.48 %

Market Cap.	Revenues TTM	Net Income TTM
$ 3,052.519 mill.	$ 1,372.814 mill.	$ 130.065 mill.
Employees	Shares Outstanding	P/E
4,209	51 mill.	23.78
Revenue Growth	Income Growth
MRQ Y/Y 3.48 %	MRQ Y/Y 20.02 %

MUX

$7.39

$-1.3200

-15.15%
Last 5 Days

MUX

$7.39

$-1.3200

-15.15%

Mcewen Mining Inc

Mcewen Mining Inc stock went down -15.15% during the last 5 days.

Mcewen Mining Inc*s business model focuses on the exploration, development, and production of precious metals such as gold and silver.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 383.933 mill.	$ 199.634 mill.	$ 105.762 mill.	52 mill.	3.38	Y/Y 36.05 %

Market Cap.	Revenues TTM	Net Income TTM
$ 383.933 mill.	$ 199.634 mill.	$ 105.762 mill.
Employees	Shares Outstanding	P/E
150	52 mill.	3.38
Revenue Growth	Income Growth
MRQ Y/Y 36.05 %	MRQ Y/Y - %

PDSB

$1.36

$-0.2400

-15.00%
Last 5 Days

PDSB

$1.36

$-0.2400

-15.00%

Pds Biotechnology Corp

Pds Biotechnology Corp shares declined -15.00% during the last 5 days.

Pds Biotechnology Corp is a biotechnology company that focuses on developing innovative immunotherapies for the treatment of various cancers and infectious diseases. Their business model revolves around leveraging their proprietary Versamune? platform to design and develop novel vaccines and immunotherapies with enhanced efficacy compared to traditional approaches. Pds Biotechnology Corp also collaborates with pharmaceutical companies and research institutions to advance their product pipeline and explore potential applications of their technology.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 49.903 mill.	$ - mill.	$ -40.679 mill.	37 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 49.903 mill.	$ - mill.	$ -40.679 mill.
Employees	Shares Outstanding	P/E
25	37 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

QNCX

$1.42

$-0.2500

-14.97%
Last 5 Days

QNCX

$1.42

$-0.2500

-14.97%

Quince Therapeutics Inc

Quince Therapeutics Inc stock went down -14.97% during the last 5 days.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 61.293 mill.	$ - mill.	$ 10.287 mill.	43 mill.	-	Y/Y - %

Market Cap.	Revenues TTM	Net Income TTM
$ 61.293 mill.	$ - mill.	$ 10.287 mill.
Employees	Shares Outstanding	P/E
54	43 mill.	-
Revenue Growth	Income Growth
MRQ Y/Y - %	MRQ Y/Y - %

FORM

$35.045

$-6.0750

-14.77%
Last 5 Days

FORM

$35.045

$-6.0750

-14.77%

Formfactor inc

Formfactor Inc shares declined -14.77% during the last 5 days.

Formfactor Inc*s business model involves designing, manufacturing, and selling advanced semiconductor wafer probe cards and probe stations, which are essential tools in the semiconductor testing process. Their products enable semiconductor manufacturers to test and validate their integrated circuit designs, ensuring high-quality and reliable performance.

Market Cap.	Revenues TTM	Net Income TTM	Shares Outstanding	P/E	Revenue Growth
$ 2,748.895 mill.	$ 740.907 mill.	$ 135.755 mill.	78 mill.	20.41	Y/Y 21.26 %

Market Cap.	Revenues TTM	Net Income TTM
$ 2,748.895 mill.	$ 740.907 mill.	$ 135.755 mill.
Employees	Shares Outstanding	P/E
2,115	78 mill.	20.41
Revenue Growth	Income Growth
MRQ Y/Y 21.26 %	MRQ Y/Y 328.64 %